Apixaban versus warfarin in patients with atrial fibrillation

Granger, Christopher B., Alexander, John H., McMurray, John J.V., Lopes, Renato D., Hylek, Elaine M., Hanna, Michael, Al-Khalidi, Hussein R., Ansell, Jack +24 more·2011·New England Journal of Medicine
DOI 10.1056/nejmoa1107039

Cited by (1,013)

Items 901–1,000 of 1,013

  1. Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions
    Luigi Di Biase · 2016 · Journal of the American Heart Association
  2. Antithrombotic Therapy to Prevent Recurrent Strokes in Ischemic Cerebrovascular Disease
    Víctor J. Del Brutto, Seemant Chaturvedi, Hans‐Christoph Diener, José G. Romano, Ralph L. Sacco · 2019 · Journal of the American College of Cardiology
  3. Antiplatelet and Anticoagulant Agents in Heart Failure
    Paul Alfred Gurbel, Udaya S. Tantry · 2014 · JACC Heart Failure
  4. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS <sub>2</sub> to the CHA <sub>2</sub> DS <sub>2</sub> -VASc Score for Thromboembolic Risk Assessment: Analysis From the National Cardiovascular Data Registry’s Outpatient Practice Innovation and Clinical Excellence Atrial Fibrillation Registry
    Katz, David F., Maddox, Thomas M., Turakhia, Mintu, Gehi, Anil, O’Brien, Emily C., Lubitz, Steven A., Turchin, Alexander, Doros, Gheorghe, Lei, Lanyu, Varosy, Paul et al. · 2017 · Circulation: Cardiovascular Quality and Outcomes
  5. New oral anticoagulant agents – general features and outcomes in subsets of patients
    Sam Schulman · 2014 · Thrombosis and Haemostasis
  6. Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin for Stroke Prevention in Non-Valvular Atrial Fibrillation: A Cost-Effectiveness Analysis
    Carla Rognoni, Monia Marchetti, Silvana Quaglini, Nicola Lucio Liberato · 2013 · Clinical Drug Investigation
  7. European Primary Care Cardiovascular Society (EPCCS) consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care
    Richard F. Hobbs, Clare J Taylor, Geert Jan Geersing, Frans Hendrik Rutten, Judith Rixt Brouwer, on behalf of the European Primary Care Cardiovascular Society (EPCCS) SPAF working group · 2015 · European Journal of Preventive Cardiology
  8. Comparative risk of major bleeding with new oral anticoagulants (NOACs) and phenprocoumon in patients with atrial fibrillation: a post-marketing surveillance study
    Stefan Hans Hohnloser, Edin Basic, Michael Näbauer · 2017 · Clinical Research in Cardiology
  9. Comparison of effectiveness and safety of treatment with apixaban vs. other oral anticoagulants among elderly nonvalvular atrial fibrillation patients
    Steven Bruce Deitelzweig, Xuemei Luo, Kiran B. Gupta, Jeffrey N. Trocio, Jack Mardekian, Tammy G. Curtice, Melissa Lingohr-Smith, Brandy Menges, Jay Lin · 2017 · Current Medical Research and Opinion
  10. Risk of ischemic stroke after atrial fibrillation diagnosis: A national sample cohort
    Mi Kyoung Son, Nam-Kyoo Lim, Hyung Woo Kim, Hyun‐Young Park · 2017 · PLoS ONE
  11. Non-Vitamin K Oral Anticoagulants in Comparison to Phenprocoumon in Geriatric and Non-Geriatric Patients with Non-Valvular Atrial Fibrillation
    Christopher Hohmann, Stefan Hans Hohnloser, Josephine Jacob, Jochen Walker, Stephan Ernst Baldus, Roman Pfister · 2019 · Thrombosis and Haemostasis
  12. Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French healthcare databases, 2011–2016
    Géric Maura, Cécile Billionnet, Jérôme Drouin, Alain Weill, Anke Neumann, Antoine Pariente · 2019 · BMJ Open
  13. 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation
    Stylianos E. Tzeis, Edward P. Gerstenfeld, Jonathan M. Kalman, Eduardo Saad, Alireza Sepehri Shamloo, Jason G. Andrade, Chirag R. Barbhaiya, Tina Baykaner, Serge Bovéda, Hugh G Calkins et al. · 2024 · Journal of Interventional Cardiac Electrophysiology
  14. A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation
    Kehinde O. Obamiro, Leanne Chalmers, Lre Bereznicki · 2016 · American Journal of Cardiovascular Drugs
  15. Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials
    Shweta Sahay, Luis Nombela-Franco y, Josep Rodés‐Cabau, Pilar Jiménez‐Quevedo, Pablo Salinas, Corina Biagioni, Ivan Javier Nuñez-Gil, Nieves Gonzalo, José Alberto de Agustín, María Del Trigo et al. · 2016 · Heart
  16. Factors associated with non–vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)
    Benjamin Adam Steinberg, Peter J. Shrader, Laine Elliott Thomas, Jack Ansell, Gregg C. Fonarow, Bernard John Gersh, Elaine M. Hylek, Peter Russell Kowey, Kenneth W. Mahaffey, Emily Claire O'Brien et al. · 2017 · American Heart Journal
  17. Atrial fibrillation in cancer patients: Hindsight, insight and foresight
    Benoîte Méry, Jean-Baptiste Guichard, Jean‐Baptiste Guy, Alexis Vallard, Jean Barthélemy, Antoine Da Costa, Nicolas Magné, Laurent Bertoletti · 2017 · International Journal of Cardiology
  18. Global Prospective Safety Analysis of Rivaroxaban
    Paulus F. Kirchhof, Ghazi Ahmad Radaideh, Young‐Hoon Kim, Fernando Tomas Lanas, Sylvia K. Haas, Pierre Amarenco, Alexander G.G. Turpie, Miriam Bach, Marc Lambelet, Susanne Hess et al. · 2018 · Journal of the American College of Cardiology
  19. Prevalence and Resolution of Left Atrial Thrombus in Patients With Nonvalvular Atrial Fibrillation and Flutter With Oral Anticoagulation
    Adam Niku, Takahiro Shiota, Robert James Siegel, Florian Rader · 2018 · The American Journal of Cardiology
  20. Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
    Karsten Bruins Slot, Eivind Berge · 2018 · Cochrane Database of Systematic Reviews
  21. Atrial fibrillation
    M. Thomas, Liqun Wu, K. Win · 2014 · Journal of Biomedical Research
  22. Management of acute stroke in patients taking novel oral anticoagulants
    Hankey, Graeme J., Norrving, Bo, Hacke, Werner, Steiner, Thorsten · 2014 · International Journal of Stroke
  23. Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation
    Ziad Hijazi, Lars C. Wallentin, Johan Lindbäck, John Hunter Alexander, Stuart J. Connolly, John W. Eikelboom, Michael D. Ezekowitz, Christopher Bull Granger, Renato D. Lópes, Tymon Pol et al. · 2020 · Journal of the American Heart Association
  24. Updated guidelines on outpatient anticoagulation.
    Patricia R. Wigle, Bradley E. Hein, Hanna E. Bloomfield, Matthew R. Tubb, Michael Doherty · 2013 · PubMed
  25. Percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation: an update
    Ole De Backer, Samer Arnous, Nikolaj Ihlemann, Niels Grove Vejlstrup, Erik Ole Jørgensen, Steen Michael Pehrson, Torben Krieger, Pascal Meier, Lars Søndergaard, Olaf Walter Franzen · 2014 · Open Heart
  26. Apixaban in patients with atrial fibrillation and prior coronary artery disease: Insights from the ARISTOTLE trial
    Maria Cecilia Bahit, Renato D. Lópes, DANIEL M. WOJDYLA, Stefan Hans Hohnloser, John Hunter Alexander, Basil S. Lewis, Philip E. Aylward, Freek W.A. Verheugt, Mátyás Keltai, Rafael Díaz et al. · 2013 · International Journal of Cardiology
  27. Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research: Implementing the patient-driven research paradigm to aid decision making in stroke care
    Ying Xian, Emily Claire O'Brien, Gregg C. Fonarow, DaiWai M. Olson, Lee H. Schwamm, Deidre Hannah, Brianna Lindholm, Lesley Maisch, Barbara L. Lytle, Melissa A. Greiner et al. · 2015 · American Heart Journal
  28. Risk of gastrointestinal bleeding during anticoagulant treatment
    Aitor Lanas-Gimeno, Angel Lanas · 2017 · Expert Opinion on Drug Safety
  29. Long-term bleeding risk prediction in ‘real world’ patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores
    Vanessa Roldán, Vicente Vicente, Mariano Valdés, Gregory Y.H. Lip, María Asunción Esteve‐Pastor, José Miguel Rivera‐Caravaca, Francisco R. Marín · 2017 · Thrombosis and Haemostasis
  30. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population‐Based Study
    Amy Yu, Shaun Malo, Lawrence W. Svenson, Stephen B. Wilton, Michael D. Hill · 2017 · Journal of the American Heart Association
  31. Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial Fibrillation: A Systematic Review and Meta‐Analysis
    Yuqing Deng, Yifan Tong, Yuanyuan Deng, Le Zou, Shunhui Li, Hui Chen · 2019 · Journal of the American Heart Association
  32. Comparison of Safety of Left Atrial Catheter Ablation Procedures for Atrial Arrhythmias Under Continuous Anticoagulation With Apixaban Versus Phenprocoumon
    Bernhard M. Kaess, Sonia Ammar, Tilko Reents, Roger Dillier, Carsten Lennerz, Verena Semmler, Christian Grebmer, Felix J. Bourier, Alessandra Buiatti, Christof Kolb et al. · 2014 · The American Journal of Cardiology
  33. Safety of new oral anticoagulant drugs: a perspective
    Juan Antonio Vilchez, Pilar Gallego, Gregory Y.H. Lip · 2013 · Therapeutic Advances in Drug Safety
  34. Stroke risk stratification in atrial fibrillation: a review of common risk factors
    Oreoluwa D Oladiran, Ifeanyi F Nwosu · 2019 · Journal of Community Hospital Internal Medicine Perspectives
  35. The pharmacology of novel oral anticoagulants
    Tracy A. DeWald, Richard Clinton Becker · 2013 · Journal of Thrombosis and Thrombolysis
  36. Stratifying the Risks of Oral Anticoagulation in Patients With Liver Disease
    Lydia M. Efird, Daniel S. Mishkin, Dan R. Berlowitz, Arlene S. Ash, Elaine M. Hylek, Al Ozonoff, Joel I. Reisman, Shibei Zhao, Guneet Kaur Jasuja, Adam J. Rose · 2014 · Circulation Cardiovascular Quality and Outcomes
  37. Novel Oral Anticoagulant Use Among Patients With Atrial Fibrillation Hospitalized With Ischemic Stroke or Transient Ischemic Attack
    Priyesh Ashok Patel, Xin Zhao, Gregg C. Fonarow, Barbara L. Lytle, Eric Edward Smith, Ying Xian, Deepak L. Bhatt, Eric David Peterson, Lee H. Schwamm, Adrian F. Hernandez · 2015 · Circulation Cardiovascular Quality and Outcomes
  38. Investigating the Enteroenteric Recirculation of Apixaban, a Factor Xa Inhibitor: Administration of Activated Charcoal to Bile Duct-Cannulated Rats and Dogs Receiving an Intravenous Dose and Use of Drug Transporter Knockout Rats
    Donglu Zhang, Charles E. Frost, Kan He, A. David Rodrigues, Xiaoli Wang, Lifei Wang, Theunis C. Goosen, William Griffith Humphreys · 2013 · Drug Metabolism and Disposition
  39. Timing of anticoagulation therapy in patients with acute ischaemic stroke and atrial fibrillation
    Maurizio Paciaroni, Giancarlo Agnelli, Walter Ageno, Valeria Caso · 2016 · Thrombosis and Haemostasis
  40. 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter
    Paul A. Heidenreich, Penelope Solis, N.A. Mark Estes, Gregg C. Fonarow, Corrine Y. Jurgens, Joseph Edward Marine, David D. McManus, Robert L. McNamara · 2016 · Circulation Cardiovascular Quality and Outcomes
  41. Major Gastrointestinal Bleeding Often Is Caused by Occult Malignancy in Patients Receiving Warfarin or Dabigatran to Prevent Stroke and Systemic Embolism From Atrial Fibrillation
    Kathryn Friedman Flack, Jay Desai, Jennifer M. Kolb, Prapti Chatterjee, Lars C. Wallentin, Michael D. Ezekowitz, Salim Yusuf, Stuart J. Connolly, Paul A. Reilly, Martina Brueckmann et al. · 2016 · Clinical Gastroenterology and Hepatology
  42. Interventional left atrial appendage closure vs novel anticoagulation agents in patients with atrial fibrillation indicated for long-term anticoagulation (PRAGUE-17 study)
    Pavel P. Osmancik, Petr Toušek, Dalibor Heřman, Petr Neužil, Pavel Hála, Josef Šťásek, Luděk Haman, Petr Kala, Martin Poloczek, Marian Branny et al. · 2016 · American Heart Journal
  43. Plasma contact factors as therapeutic targets
    Benjamin F. Tillman, András Gruber, Owen J. T. McCarty, David Gailani · 2018 · Blood Reviews
  44. Atrial fibrillation in acute heart failure: A position statement from the Acute Cardiovascular Care Association and European Heart Rhythm Association of the European Society of Cardiology
    Bülent Görenek, Sigrun Halvorsen, Gulmira Kudaiberdieva, Héctor Bueno, Isabelle C. Van Gelder, Maddalena Lettino, Francisco R. Marín, Josep Masip, Christian Eugen Mueller, Sercan Okutucu et al. · 2020 · European Heart Journal Acute Cardiovascular Care
  45. Rationale, considerations, and goals for atrial fibrillation centers of excellence: A Heart Rhythm Society perspective
    Jonathan Paul Piccini, James David Allred, Thomas Jared Bunch, Thomas F. Deering, Luigi Di Biase, Ayman Ali Hussein, William R. Lewis, Suneet Mittal, Andrea Natale, José Osorio et al. · 2020 · Heart Rhythm
  46. New oral anticoagulants: discussion on monitoring and adherence should start now!
    Hugo Ten Cate · 2013 · Thrombosis Journal
  47. Resolution of left atrial appendage thrombus with apixaban
    Tohru Kawakami, Hiroko Kobayakawa, Hiroyoshi Ohno, Nobukiyo Tanaka, Hiroki Ishihara · 2013 · Thrombosis Journal
  48. Non-vitamin K Antagonist Oral Anticoagulants vs. Warfarin at Risk of Fractures: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Zhi‐Chun Gu, Lingyun Zhou, Long Shen, Chi Zhang, Jun Pu, Hou‐Wen Lin, Xiao-Yan Liu · 2018 · Frontiers in Pharmacology
  49. Changes in Oral Anticoagulation Therapy over One Year in 51,000 Atrial Fibrillation Patients at Risk for Stroke: A Practice-Derived Study
    Stefan Hans Hohnloser, Edin Basic, Michael Näbauer · 2019 · Thrombosis and Haemostasis
  50. Antithrombotic therapy in diabetes: which, when, and for how long?
    Ramzi Ajjan, Noppadol Kietsiriroje, Lina Badimón, Gemma Vilahur, Diana Adrienne Gorog, Dominick Joseph Angiolillo, David Russell, Bianca Rocca, Robert F. Storey · 2021 · European Heart Journal
  51. Acute, periprocedural and longterm antithrombotic therapy in older adults
    Felicita Andreotti, Tobias Geisler, Jean‐Philippe Collet, Bruna Gigante, Diana Adrienne Gorog, Sigrun Halvorsen, Gregory Y.H. Lip, João Morais, Eliano Pio Navarese, Carlo Patrono et al. · 2022 · European Heart Journal
  52. Efficacy and safety of novel oral anticoagulants in patients with bioprosthetic valves
    Ajay Yadlapati, Christopher A. Groh, S. Chris Malaisrie, Mark M. Gajjar, Jane T. Kruse, Sheridan N. Meyers, ROD S. PASSMAN · 2015 · Clinical Research in Cardiology
  53. Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: A review of the literature
    Cecilia Becattini, Maria Cristina Vedovati, Giancarlo Agnelli · 2012 · Thrombosis Research
  54. New Direct Oral Anticoagulants (DOAC) and Their Use Today
    Heike Schwarb, Dimitrios A. Tsakiris · 2016 · Dentistry Journal
  55. Ablation of Atrial Fibrillation
    Mark S. Link, Michel Haı̈ssaguerre, Andrea Natale · 2016 · Circulation
  56. Systematic review and network meta-analysis of stroke-prevention treatments in patients with atrial fibrillation
    Amy Tawfik, JOANNA M. BIELECKI, Murray Dale Krahn, Paul Dorian, Jeffrey S. Hoch, Heather Shirley Boon, Don Husereau, Petros Pechlivanoglou · 2016 · Clinical Pharmacology Advances and Applications
  57. Non-vitamin K antagonist oral anticoagulants have better efficacy and equivalent safety compared to warfarin in elderly patients with atrial fibrillation: A systematic review and meta-analysis
    In‐Soo Kim, Hyun-Jung Kim, Tae‐Hoon Kim, Jae‐Sun Uhm, Boyoung Joung, Moon‐Hyoung Lee, Hui‐Nam Pak · 2018 · Journal of Cardiology
  58. Trends in initiation of direct oral anticoagulant therapies for atrial fibrillation in a national population-based cross-sectional study in the French health insurance databases
    Laëtitia Huiart, Cyril Ferdynus, Christel Renoux, Amélie Beaugrand, Sophie Lafarge, Léa Bruneau, Samy Suissa, Olivier Maillard, Xavier Ranouil · 2018 · BMJ Open
  59. Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome
    Oscar Ö. Braun, Besim Bico, Uzma A. Chaudhry, Henrik Wagner, Sasha M. Koul, Patrik Tydén, Fredrik Scherstén, Stefan V. Jovinge, Peter J Svensson, J. Gustav Smith et al. · 2014 · Thrombosis Research
  60. Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management—a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis
    Alexander Niessner, Juan Luis Tamargo, João Morais, Lorenz Koller, Sven Waßmann, Steen Husted, Christian Tobias Torp-Pedersen, Keld P. Kjeldsen, Basil S. Lewis, Heinz Drexel et al. · 2015 · European Heart Journal
  61. Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life
    Cecilia Becattini, Laura Franco, Jan Beyer‐Westendorf, Luca Masotti, Cinzia Nitti, Simone Vanni, Giorgia Manina, Sergio Cattinelli, Roberto Cappelli, Rodolfo Sbrojavacca et al. · 2016 · International Journal of Cardiology
  62. Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban
    Ping G. Tepper, Jack Mardekian, Cristina Masseria, Hemant M. Phatak, Shital Kamble, Younos Abdulsattar, William Petkun, Gregory Y.H. Lip · 2018 · PLoS ONE
  63. Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation
    Alexander Philipp Benz, Stefan Hans Hohnloser, John W. Eikelboom, Anthony Carnicelli, Robert Patrick Giugliano, Christopher Bull Granger, Josephine Harrington, Ziad Hijazi, David A. Morrow, Manesh R. Patel et al. · 2023 · European Heart Journal
  64. Rethinking coagulation: from enzymatic cascade and cell-based reactions to a convergent model involving innate immune activation
    Jun Yong, Cheng‐Hock Toh · 2023 · Blood
  65. Relevance of P-glycoprotein in stroke prevention with dabigatran, rivaroxaban, and apixaban
    Claudia Stöllberger, Josef Finsterer · 2015 · Herz
  66. Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome
    Deepa J. Arachchillage, Ian J. Mackie, Maria Efthymiou, David Alan Isenberg, Samuel J. Machin, Hannah Cohen · 2015 · Journal of Thrombosis and Haemostasis
  67. Cryptogenic stroke: Is silent atrial fibrillation the culprit?
    Taya V. Glotzer, Paul Ziegler · 2014 · Heart Rhythm
  68. An evidence summary of the management of patients taking direct oral anticoagulants (DOACs) undergoing dental surgery
    S. Johnston · 2016 · International Journal of Oral and Maxillofacial Surgery
  69. Early real-world evidence of persistence on oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a cohort study in UK primary care
    Michelle E Johnson, Cinira Lefèvre, Shuk‐Li Collings, David Evans, Sebastian Kloss, Essra Ridha, Andrew Maguire · 2016 · BMJ Open
  70. Stroke and bleeding with non-vitamin K antagonist oral anticoagulant or warfarin treatment in patients with non-valvular atrial fibrillation: a population-based cohort study
    Tomas Forslund, Björn Wettermark, Morten Tolstrup Andersen, Paul Hjemdahl · 2017 · EP Europace
  71. Interpatient Variation in Rivaroxaban and Apixaban Plasma Concentrations in Routine Care
    Markus Gulilat, ANTHONY S.L. TANG, Steven E. Gryn, Peter Leong‐Sit, Allan Cameron Skanes, Jeffrey Alfonsi, George K. Dresser, Sara L. Henderson, Rhiannon V. Rose, Daniel J. Lizotte et al. · 2017 · Canadian Journal of Cardiology
  72. Pharmacokinetics of new oral anticoagulants: implications for use in routine care
    Ylenia Ingrasciotta, Salvatore Crisafulli, Valeria Pizzimenti, Ilaria Marcianò, Anna Mancuso, Giuseppe Andò, Salvatore Corrao, Piera Capranzano, Gianluca Trifirò · 2018 · Expert Opinion on Drug Metabolism & Toxicology
  73. Non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: A systematic review with meta-analysis and trial sequential analysis
    Daniel Caldeira, A Nunes-Ferreira, Raquel Olmedo Rodrigues, Eunice Vicente, Fausto José Pinto, Joaquim José Ferreira · 2018 · Archives of Gerontology and Geriatrics
  74. Continued Versus Interrupted Oral Anticoagulation During Transfemoral Transcatheter Aortic Valve Implantation and Impact of Postoperative Anticoagulant Management on Outcome in Patients With Atrial Fibrillation
    Norman Mangner, Lisa Crusius, Stephan Haußig, Felix J. Woitek, Philipp Kiefer, Georg Stachel, Sergey Leontyev, Florian Schlotter, Aileen Spindler, Robert Höllriegel et al. · 2019 · The American Journal of Cardiology
  75. Disparities and Temporal Trends in the Use of Anticoagulation in Patients With Ischemic Stroke and Atrial Fibrillation
    Nicole Beaton Sur, Kefeng Wang, Marco R. Di Tullio, Carolina M Gutierrez, Chuanhui Dong, Sebastian Koch, Hannah E. Gardener, Enid J García-Rivera, Juan Carlos Zevallos, William Scott Burgin et al. · 2019 · Stroke
  76. Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation
    Sachin J. Shah, Daniel E. Singer, Margaret C. Fang, Kristi Reynolds, Alan S. Go, Mark H. Eckman · 2019 · Circulation Cardiovascular Quality and Outcomes
  77. Risk of Hospitalization With Hemorrhage Among Older Adults Taking Clarithromycin vs Azithromycin and Direct Oral Anticoagulants
    Kevin M. Hill, Ewa Sucha, Emily Rhodes, Marc Carrier, Amit X. Garg, Ziv Harel, Gregory L. Hundemer, Edward G. Clark, Greg A. Knoll, Eric McArthur et al. · 2020 · JAMA Internal Medicine
  78. Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients
    Tiziano Barbui, Valerio De Stefano, Alessandra Carobbio, Alessandra Iurlo, Alberto Álvarez‐Larrán, Beatriz Cuevas, Francisca Ferrer‐Marín, Alessandro Maria Vannucchi, Francesca Palandri, Claire N. Harrison et al. · 2021 · Leukemia
  79. Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation
    Danielle Clarkesmith, Helen M. Pattison, Deirdre A. Lane · 2013 · Cochrane Database of Systematic Reviews
  80. Stability‐indicating RP‐HPLC method development and validation for determination of nine impurities in apixaban tablet dosage forms. Robustness study by quality by design approach
    Velusamy B. Subramanian, Naresh Kumar Katari, Thirupathi Dongala, Sreekantha Babu Jonnalagadda · 2019 · Biomedical Chromatography
  81. Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding
    Gregory Y.H. Lip, Allison V. Keshishian, Yan Zhang, Amiee Luan Kang, Amol D. Dhamane, Xuemei Luo, Christian Klem, Mauricio Ferri, Jenny Z. Jiang, Hüseyin Yüce et al. · 2021 · JAMA Network Open
  82. Time trends in atrial fibrillation-related stroke during 2001–2020 in Sweden: a nationwide, observational study
    Mozhu Ding, Marcus Ebeling, Louise Ziegler, Alexandra M. V. Wennberg, Karin Modig · 2023 · The Lancet Regional Health - Europe
  83. Global Burden of Atrial Fibrillation and Flutter by National Income: Results From the Global Burden of Disease 2019 Database
    Amelie H. Ohlrogge, Jan Brederecke, Renate B. Schnabel · 2023 · Journal of the American Heart Association
  84. Evaluation of the effect of naproxen on the pharmacokinetics and pharmacodynamics of apixaban
    Charles E. Frost, Andrew Shenker, Mohit D. Gandhi, Janice M. Pursley, Yu Chen Barrett, Jessie J.J. Wang, Donglu Zhang, Wonkyung Byon, Rebecca A. Boyd, Frank P. LaCreta · 2014 · British Journal of Clinical Pharmacology
  85. Sex Differences in Dabigatran Use, Safety, And Effectiveness In a Population-Based Cohort of Patients With Atrial Fibrillation
    Meytal Avgil Tsadok, Cynthia Anne Jackevicius, Elham Rahme, Karin H. Humphries, Louise Pilote · 2015 · Circulation Cardiovascular Quality and Outcomes
  86. Nine-Year Trend of Anticoagulation Use, Thromboembolic Events, and Major Bleeding in Patients With Non-Valvular Atrial Fibrillation – Shinken Database Analysis –
    Shinya S. Suzuki, Takayuki Otsuka, Koichi Sagara, Hiroaki Semba, Hiroto Kano, Shunsuke Matsuno, Hideaki Takai, Yuko Kato, Tokuhisa Uejima, Yuji Oikawa et al. · 2016 · Circulation Journal
  87. How does Chronic Atrial Fibrillation Influence Mortality in the Modern Treatment Era?
    Rajiv Sankaranarayanan, Graeme J. Kirkwood, Rajaverma Visweswariah, David J. Fox · 2015 · Current Cardiology Reviews
  88. Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis
    Henri M.H. Spronk, Teresa Padró, Joylene E. Siland, Jürgen H. Prochaska, Joris Winters, Allard C. van der Wal, Jelle J. Posthuma, Gordon D O Lowe, Elisa D’Alessandro, Philip Wenzel et al. · 2018 · Thrombosis and Haemostasis
  89. Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF
    Sylvia K. Haas, A. John Camm, Jean‐Pierre Bassand, Pantep Angchaisuksiri, Frank J.S. Cools, Ramon L. Corbalan, Harry H. Gibbs, Barry Frank Jacobson, Yukihiro Koretsune, Lorenzo Giovanni Mantovani et al. · 2019 · American Heart Journal
  90. Antithrombotic Therapy and Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation
    Ioanna Kosmidou, Yangbo Liu, Maria C. Alu, Mengdan Liu, Mahesh V. Madhavan, Tarun Chakravarty, Raj Makkar, Vinod H. Thourani, ANGELO B. BIVIANO, Susheel Kodali et al. · 2019 · JACC: Cardiovascular Interventions
  91. Measuring the anticoagulant effects of target specific oral anticoagulants—reasons, methods and current limitations
    Helen Mani, Alexander Kasper, Edelgard Lindhoff‐Last · 2013 · Journal of Thrombosis and Thrombolysis
  92. Risk of Fatal Bleeding in Episodes of Major Bleeding with New Oral Anticoagulants and Vitamin K Antagonists: A Systematic Review and Meta-Analysis
    Joel Skaistis, Travis Tagami · 2015 · PLoS ONE
  93. Adherence to warfarin treatment among patients with atrial fibrillation
    Mika Skeppholm, Leif Friberg · 2014 · Clinical Research in Cardiology
  94. Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service – results from the prospective, multi-center, observational cohort study thrombEVAL
    Jürgen H. Prochaska, Sebastian Göbel, Karsten Keller, Meike Coldewey, Alexander Ullmann, Heidrun Lamparter, Claus Jünger, Zaid Al‐Bayati, Christina Baer, Ulrich Walter et al. · 2015 · BMC Medicine
  95. Intracerebral haemorrhage associated with antithrombotic treatment: translational insights from experimental studies
    Arne Lauer, Waltraud Pfeilschifter, Chris B. Schaffer, Eng H. Lo, Christian Foerch · 2013 · The Lancet Neurology
  96. Use of Warfarin at Discharge Among Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation in China
    Xiaomeng Yang, Zixiao Li, Xingquan Zhao, Chunjuan Wang, Liping Liu, Chunxue Wang, Yuesong Pan, Hao Li, David Wang, Robert G. Hart et al. · 2015 · Stroke
  97. Cost-Effectiveness of Oral Anticoagulants for Ischemic Stroke Prophylaxis Among Nonvalvular Atrial Fibrillation Patients
    Anuj Shah, Anand R. Shewale, Corey J. Hayes, Bradley C. Martin · 2016 · Stroke
  98. The Atrial Fibrillation Health Literacy Information Technology System: Pilot Assessment
    Magnani, Jared W, Schlusser, Courtney L, Kimani, Everlyne, Rollman, Bruce L, Paasche-Orlow, Michael K, Bickmore, Timothy W · 2017 · JMIR Cardio
  99. A systematic review of network meta-analyses among patients with nonvalvular atrial fibrillation: a comparison of efficacy and safety following treatment with direct oral anticoagulants
    Cohen, A.T., Hill, N.R., Luo, X., Masseria, C., Abariga, S.A., Ashaye, A.O. · 2018 · International Journal of Cardiology
  100. Atrial Fibrillation, Cognitive Decline, and Dementia: an Epidemiologic Review
    Ding, Mozhu, Qiu, Chengxuan · 2018 · Current Epidemiology Reports